RPS18 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
Gene Overview
RPS18 (Ribosomal Protein S18) encodes a conserved ribosomal protein component of the 40S small ribosomal subunit. The RPS18 protein is essential for protein synthesis and is involved in the assembly and function of the ribosome, the cellular machinery responsible for translating mRNA into proteins. In humans, RPS18 is ubiquitously expressed across all tissues, with particularly high levels in metabolically active cells including neurons.
Protein Structure and Function
RPS18 is a member of the ribosomal protein S18 family and is structurally conserved across eukaryotes. The protein contains the characteristic S18 domain and binds to 18S rRNA to form part of the 40S subunit decoding center. Key functions include:
Ribosomal Assembly: RPS18 participates in the early stages of 40S subunit biogenesis in the nucleolus
Translation Initiation: The protein contributes to the formation of the pre-initiation complex (PIC) that scans mRNA for start codons
tRNA Binding: RPS18 interacts with the A-site of the ribosome, facilitating tRNA accommodation during translation elongation
Quality Control: The protein plays a role in the nonsense-mediated decay (NMD) pathway, recognizing premature termination codons
Expression and Localization
RPS18 is expressed at high levels throughout the brain, particularly in:
Pyramidal neurons of the cortex and hippocampus
Cerebellar Purkinje cells
Dopaminergic neurons of the substantia nigra
Astrocytes and oligodendrocytes
The protein is primarily localized to the cytoplasm where ribosomes are concentrated, but can also be found associated with the endoplasmic reticulum (ER) in neurons engaged in local protein synthesis at synapses.
Role in Neurodegeneration
Dysregulation of RPS18 and ribosomal function has been implicated in several neurodegenerative diseases:
Alzheimer's Disease (AD)
Ribosomal dysfunction is an early hallmark of AD, with global translation deficits observed in affected brain regions
RPS18 expression is altered in the hippocampus and entorhinal cortex of AD patients
Impaired ribosomal biogenesis contributes to synaptic protein synthesis deficits and synaptic loss
The protein interacts with pathways involved in tau phosphorylation and amyloid processing
Parkinson's Disease (PD)
RPS18 is dysregulated in the substantia nigra of PD patients
Ribosomal stress induced by mitochondrial dysfunction leads to RPS18 redistribution
The protein participates in the cellular stress response to dopaminergic neuron injury
Amyotrophic Lateral Sclerosis (ALS)
Mutations in ribosomal proteins have been linked to ALS and frontotemporal dementia
RPS18 dysregulation contributes to impaired RNA metabolism in motor neurons
Clinical Significance
Genetic Associations
RPS18 polymorphisms have been associated with susceptibility to neurodegenerative diseases
Copy number variations involving the RPS18 gene locus (6p21.3) have been reported in neuropsychiatric conditions
Biomarker Potential
Cerebrospinal fluid (CSF) levels of ribosomal proteins may serve as biomarkers for neuronal injury
RPS18-specific antibodies have been detected in some patients with autoimmune encephalitis
Therapeutic Implications
Strategies to enhance ribosomal function and restore translation homeostasis are being explored
Small molecules targeting ribosomal biogenesis pathways show promise in preclinical models
Interactome
RPS18 interacts with numerous proteins involved in translation and neurodegeneration: